Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The age of vaccines.

Scully T.

Nature. 2014 Mar 6;507(7490):S2-3. No abstract available.

PMID:
24611167
3.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
4.

Update on pertussis and diphtheria-tetanus toxoids-pertussis vaccination new strategies for clinicians. Introduction.

Cherry JD.

Pediatr Infect Dis J. 1997 Apr;16(4 Suppl):S76-7. No abstract available.

PMID:
9109160
5.

Routine vaccines across the life span, 2003.

Zimmerman RK, Middleton DB, Burns IT, Clover RD.

J Fam Pract. 2003 Jan;52(1 Suppl):S1-21. Review.

PMID:
12556275
6.

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.

Pediatrics. 2006 Sep;118(3):e602-9.

PMID:
16950952
7.

FDA approval of a second acellular pertussis vaccine for use among infants and young children.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1997 Feb 7;46(5):110-1.

8.

Global routine vaccination coverage, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1367-71.

9.

Vaccination coverage of 2-year-old children--United States, 1991-1992.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1994 Jan 7;42(51-52):985-8. Erratum in: JAMA 1994 Feb 2;271(5):341.

PMID:
8272041
10.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
11.

Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.

Afari EA, Kamiya Y, Nkrumah FK, Dunyo SK, Akpedonu P, Kamiya H, Fukai F.

Ann Trop Paediatr. 1996 Mar;16(1):39-48.

PMID:
8787364
12.

Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention experience.

Chen RT, Haber P, Mullen JR.

Ann N Y Acad Sci. 1995 May 31;754:309-20. Review. No abstract available.

PMID:
7625667
13.

Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children--United States, 1989-1991.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1992 Jul 24;41(29):522-5.

PMID:
1630430
14.

FDA approval of a fourth acellular pertussis vaccine for use among infants and young children.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1998 Nov 6;47(43):934-6.

15.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.

Vaccine. 2005 May 25;23(28):3657-67.

PMID:
15882526
16.

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).

Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005530. doi: 10.1002/14651858.CD005530.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD005530.

PMID:
19588375
17.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
18.

Public health application of acellular pertussis vaccines.

Hadler SC, Orenstein WA.

Dev Biol Stand. 1997;89:355-61. Review. No abstract available.

PMID:
9272371
19.

Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials.

Cherry JD.

Pediatr Infect Dis J. 1997 Apr;16(4 Suppl):S90-6.

PMID:
9109163
20.

Maternal leave policies and vaccination coverage: a global analysis.

Daku M, Raub A, Heymann J.

Soc Sci Med. 2012 Jan;74(2):120-4. doi: 10.1016/j.socscimed.2011.10.013. Epub 2011 Nov 29.

PMID:
22196248

Supplemental Content

Support Center